E. Nigra

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials

Michele Spina, Ulrich Jaeger, Joseph A. Sparano et al. · Blood · 2004 · 190 citations · Full text

Medicine, Oncology, Pharmacology +14

Vinorelbine Is an Effective and Safe Drug for AIDS-Related Kaposi’s Sarcoma: Results of a Phase II Study

Guglielmo Nasti, D. Errante, Renato Talamini et al. · Journal of Clinical Oncology · 2000 · 58 citations

Medicine, Pharmacology, Pharmacotherapy +13

A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease

Marco Floridia, Raffaella Bucciardini, D. Ricciardulli et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1999 · 55 citations

Medicine, Pharmacology, Pharmacotherapy +17

Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: Evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients

Umberto Tirelli, D. Errante, Michele Spina et al. · Cancer · 1996 · 44 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Infusional CDE with Rituximab for the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma: Preliminary Results of a Phase I/II Study

Umberto Tirelli, Michele Spina, Ulrich Jaeger et al. · Recent results in cancer research/Recent Results in Cancer Research · 2002 · 42 citations

Life Sciences, Hematology, Immunology +9